HELICOVAXOR® Completion of Initial Programme of Work

The EC FP7 funded portion of the HELICOVAXOR® consortium is now complete and the final report has been submitted. A number of the members of the consortium continue to work together to further research oral adjuvanted vaccines. The critical needs for successful oral vaccine product development are to 1) find a bro...

Read More »


Publications by HELICOVAXOR® consortium members

Throughout the course of the HELICOVAXOR® project, members of the consortium have continued to raise awareness of the potential for an oral, adjuvanted Helicobacter pylori vaccine through presentations and publications at international conferences and in scientific journals.  A list of publications is provided below:...

Read More »


Final Report Submitted to European Commission

In March 2015, the final report on the HELICOVAXOR® project was submitted to European Commission. While the work planned under the grant has been completed, the very promising results were not sufficient to justify moving to human clinical testing. A number of the consortium members continue to work together to ...

Read More »